Malaria parasite requires a single receptor to invade human red blood cells

November 9, 2011

Researchers have today revealed a key discovery in understanding how the most deadly species of malaria parasite, Plasmodium falciparum, invades human red blood cells. Using a technique developed at the Wellcome Trust Sanger Institute, they have found that the parasite relies on a single receptor on the red blood cell's surface to invade, offering an exciting new focus for vaccine development.

Malaria kills approximately one million people every year, mostly children under the age of five in sub-Saharan Africa. Currently no licensed vaccine is available.

The blood stage of Plasmodium's lifecycle begins when the parasite invades human , and it is this stage that is responsible for the symptoms and associated with malaria. Researchers have tried for many years to develop a vaccine to prevent the parasite gaining entry into our red blood cells, but so far they have been unsuccessful. One of the challenges is that the parasite is adaptable – although several red blood cell had been previously identified, none were shown to be essential: when entry through one receptor is prevented, the parasite is able to switch to another. This new research has found a single receptor that is absolutely required by the parasite to invade.

"Our findings were unexpected and have completely changed the way in which we view the invasion process," says Dr Gavin Wright, senior co-author from the Wellcome Trust Sanger Institute. "Our research seems to have revealed an Achilles' heel in the way the parasite invades our red blood cells. It is rewarding to see how our techniques can be used to answer important biological problems and lay the foundations for new therapies."

The interaction between the parasite protein and the host receptor was discovered using a technique called AVEXIS (Avidity-based Extracellular Interaction Screen). This technology, created by Dr Gavin Wright's team at the Sanger Institute, was specifically designed to detect extracellular receptor-ligand interactions of this type.

As well as identifying the interaction, the researchers demonstrated that disrupting this interaction completely blocked the parasite from gaining entry into the red blood cell. Importantly, this was true across all parasite strains tested, making it appear that the receptor is a universal entry pathway. It is hoped that the parasite's dependency on this one protein can now be exploited to develop new and effective vaccines.

"By identifying a single receptor that appears to be essential for to invade human red blood cells, we have also identified an obvious and very exciting focus for ," says Dr Julian Rayner, senior co-author from the Sanger Institute. "The hope is that this work will lead towards an effective vaccine based around the parasite protein."

Vaccinating against malaria will be the most cost-effective and simplest way to protect populations against the disease. However, for such an approach to work at the population scale, the vaccine needs to be highly effective so that the vast majority of those vaccinated are immune to the disease. This new research identifies an exciting candidate for such a vaccine.

"Recent reports of some positive results from ongoing malaria vaccine trials in Africa are encouraging, but in the future more effective vaccines will be needed if malaria is ever to be eradicated," says Professor Adrian Hill, Wellcome Trust Senior Investigator at the Jenner Institute, Oxford. "The discovery of a single receptor that can be targeted to stop the parasite infecting red offers the hope of a far more effective solution."

More information: Crosnier et al BASIGIN is a receptor essential for erythrocyte invasion by Plasmodium falciparum. Nature doi:10.1038/nature10606

Related Stories

Recommended for you

Crystal clear images uncover secrets of hormone receptors

July 31, 2015

Many hormones and neurotransmitters work by binding to receptors on a cell's exterior surface. This activates receptors causing them to twist, turn and spark chemical reactions inside cells. NIH scientists used atomic level ...

A cheaper, high-performance prosthetic knee

July 30, 2015

In the last two decades, prosthetic limb technology has grown by leaps and bounds. Today, the most advanced prostheses incorporate microprocessors that work with onboard gyroscopes, accelerometers, and hydraulics to enable ...

Flow means 'go' for proper lymph system development

July 27, 2015

The lymphatic system provides a slow flow of fluid from our organs and tissues into the bloodstream. It returns fluid and proteins that leak from blood vessels, provides passage for immune and inflammatory cells from the ...

2 comments

Adjust slider to filter visible comments by rank

Display comments: newest first

hush1
1 / 5 (2) Nov 09, 2011
Someone post their next step. Do they have a tentative time table for their plans of strategy? Meanwhile alter all carriers and non carriers of all species to an asymmetrical wing span genetically. The least time consuming, the least expensive tentative solution till the permanent solution is realized.
pianoman
1 / 5 (4) Nov 09, 2011
An excellent cure for malaria is MMS or, sodium chlorite mixed with citric acid, invented by Jim Humble, look it up. Thanks

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.